Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting converging therapeutic pathways to overcome hypertension.

Literature DB >> 19136168

Targeting converging therapeutic pathways to overcome hypertension.

Kwang Kon Koh, Michael J Quon.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2009 PMID： 19136168 PMCID： PMC2676222 DOI： 10.1016/j.ijcard.2008.11.150

Source DB: PubMed Journal: Int J Cardiol ISSN： 0167-5273 Impact factor: 4.164

× No keyword cloud information.

11 in total

1. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors: Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal: Lancet Date: 2005 Sep 10-16 Impact factor: 79.321

Review 2. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.

Authors: Kwang Kon Koh; Seung Hwan Han; Michael J Quon
Journal: J Am Coll Cardiol Date: 2005-11-09 Impact factor: 24.094

Review 3. Adiponectin and cardiovascular disease: response to therapeutic interventions.

Authors: Seung Hwan Han; Michael J Quon; Jeong-a Kim; Kwang Kon Koh
Journal: J Am Coll Cardiol Date: 2007-01-19 Impact factor: 24.094

4. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?

Authors: S Yusuf
Journal: Circulation Date: 1995-09-01 Impact factor: 29.690

Review 5. Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.

Authors: J G Tijssen; P G Hugenholtz
Journal: Eur Heart J Date: 1996-08 Impact factor: 29.983

6. Risk stratification in hypertension: new insights from the Framingham Study.

Authors: W B Kannel
Journal: Am J Hypertens Date: 2000-01 Impact factor: 2.689

7. Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function.

Authors: Martin Rodriguez-Porcel; Lilach O Lerman; Joerg Herrmann; Tatsuya Sawamura; Claudio Napoli; Amir Lerman
Journal: Arterioscler Thromb Vasc Biol Date: 2003-03-27 Impact factor: 8.311

8. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.

Authors: Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Wook-Jin Chung; Jeong Yeal Ahn; Yiel-Hea Seo; Moon Ho Kang; Tae Hoon Ahn; In Suck Choi; Eak Kyun Shin
Journal: Circulation Date: 2004-11-29 Impact factor: 29.690

9. Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.

Authors: Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Wook-Jin Chung; Jeong Yeal Ahn; Jeong-A Kim; Yonghee Lee; Eak Kyun Shin
Journal: Diabetes Care Date: 2006-02 Impact factor: 19.112

Review 10. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

Authors: Jeong-a Kim; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal: Circulation Date: 2006-04-18 Impact factor: 29.690

4 in total

4. An analysis of the risk factors for premature coronary artery disease in young and middle-age Chinese patients with hypertension.

Authors: Jingjin Che; Guangping Li; Yuanxia Shao; Haifang Niu; Yanli Shi
Journal: Exp Clin Cardiol Date: 2013